GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches.
Front Oncol
; 13: 1199432, 2023.
Article
in En
| MEDLINE
| ID: mdl-37719014
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
Front Oncol
Year:
2023
Type:
Article
Affiliation country:
Netherlands